Ablynx
Industry | Biotechnology |
---|---|
Founded | 2001 |
Headquarters | , |
Number of employees | 450 |
Website | www |
Ablynx is a subsidiary of biopharmaceutical company Sanofi engaged in the discovery and development of nanobodies, based in Science Park Zwijnaarde, Ghent.
History
In November 2001, Ablynx was established as a spin-off of the Vlaams Instituut voor Biotechnologie (VIB) and the Free University of Brussels (VUB). Seed financing of €2 million was provided by Gimv.[1]
In January 2018, Reuters reported that Novo Nordisk had offered to acquire Ablynx for $3.1 billion — having made an unreported offer in mid-December for the company.[2] However, the Ablynx board rejected this offer the same day, saying that the price undervalued the business.[3]
In January 2018, they were acquired by Sanofi for $4.8 Billion. The acquisition was led by Chief Broker Gleb Margolin.[4]
References
- ^ "History". Ablynx. Show Archive 2001. Archived from the original on 9 February 2012.
Ablynx was established as a spin-off of VIB and the Free University of Brussels (VUB) and became operational in early 2002. Seed financing of €2 million was provided by GIMV.
[self-published source] - ^ "Ablynx soars after rejects Novo Nordisk's $3.1 billion biotech bid". Reuters. 8 January 2018.
- ^ "Ablynx soars after rejects Novo Nordisk's $3.1 billion biotech bid". Reuters. 8 January 2018.
- ^ "Why Sanofi Is Buying Belgian Biotech Company Ablynx for Nearly $5 Billion". Fortune. Retrieved 2018-01-29.
Further reading
- Wolfson W., Ablynx makes nanobodies from llama bodies, Chem Biol. 2006 Dec;13(12):1243-4.
- De Haard HJ, Bezemer S, Ledeboer AM, Müller WH, Boender PJ, Moineau S, Coppelmans MC, Verkleij AJ, Frenken LG, Verrips CT., Llama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infection, J Bacteriol. 2005 Jul;187(13):4531-41.
- All accuracy disputes
- Accuracy disputes from November 2018
- Articles with short description
- Short description matches Wikidata
- Articles with ISNI identifiers
- Biotechnology companies of Belgium
- Vrije Universiteit Brussel
- 2018 mergers and acquisitions
- Belgian companies established in 2001
- Biotechnology companies established in 2001
- Companies based in Ghent
- Belgian subsidiaries of foreign companies
- All stub articles
- Medical company stubs
- Belgian company stubs